Recombinant Anti-CD89 x Anti-HIV-1 gp41 Bispecific Antibody (Fv-IgG) is an appended IgG format, which has 2+2 antigen-binding valency. This dual variable domain IgG is generated by appending variable domains of an anti-CD89 IgG with similar domains from an anti-HIV-1 gp41 antibody via short peptide linkers, or vice versa. This BsAb can retarget macrophages to tumor cells. It is designed for the research of HIV-1 infection, AIDS therapy.
There are currently no customer reviews or questions for Recombinant Human Anti-CD89 x Human Anti-HIV-1 gp41 Bispecific Antibody (Fv-IgG) (BSDG-H306). Click the button below to contact us or submit your feedback about this product.
Welcome! For price inquiries, we will get back to you as soon as possible.
INQUIRYSERVICES
PRODUCTS
PLATFORMS